ArticleMedicina (Kaunas, Lithuania)2026
Pre-Transplant Endothelial Activation and Stress Index (EASIX) and Albumin-Modified mEASIX (mEASIX_alb) Predict Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
Tuba Güllü Koca, Nizameddin Koca, Fazıl Çağrı Hunutlu, Sinem Çubukçu, Rümeysa Yılmaz, Tuba Ersal, Vildan Gürsoy, Ibrahim Ethem Pınar, Vildan Özkocaman, Fahir Özkalemkaş
Abstract read
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Tuba Güllü KocaDepartment of Hematology, Bursa Şehir Training & Research Hospital, University of Health Sciences, 16110 Bursa, Türkiye.
Nizameddin KocaDepartment of Internal Medicine, Bursa Şehir Training & Research Hospital, University of Health Sciences, 16110 Bursa, Türkiye.ORCID 0000-0003-1457-4366 Fazıl Çağrı HunutluDepartment of Hematology, Bursa Şehir Training & Research Hospital, University of Health Sciences, 16110 Bursa, Türkiye.ORCID 0000-0002-4991-9830 Sinem ÇubukçuDepartment of Hematology, Ali Osman Sonmez Oncology Hospital, 16040 Bursa, Türkiye.
Rümeysa YılmazDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.
Tuba ErsalDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.ORCID 0000-0001-5419-3221 Vildan GürsoyDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.
Ibrahim Ethem PınarDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.ORCID 0000-0001-9907-1498 Vildan ÖzkocamanDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.
Fahir ÖzkalemkaşDepartment of Hematology, Bursa Uludağ University Hospital, Bursa Uludağ University, 16059 Bursa, Türkiye.ORCID 0000-0001-9710-134X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Multiple MyelomaAdultAgedBiomarkersFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisProportional Hazards ModelsRetrospective StudiesTransplantation, AutologousBiomarkersautologous stem cell transplantationEASIXendothelial stressmultiple myelomaPNIprognostic nutritional indexsurvival
Identifiers
PMID42654469
PMCPMC13515194
What OpenQuestion holds
Textmetadata
Read underepoch 390